GreggJSilvermanMD

PubMed

• Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination.
  Ilya Kister, Ryan Curtin, Amanda L Piquet, Tyler Borko, Jinglan Pei
  Annals of Clinical and Translational Neurology. 2024-07-01
• Impaired immune responses in the airways are associated with poor outcome in critically ill COVID-19 patients.
  Clea R Barnett, Kelsey Krolikowski, Radu Postelnicu, Vikramjit Mukherjee, Imran Sulaiman
  ERJ Open Research. 2024-07-01
• 6 citations
  The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever.
  Gregg J Silverman, Doua F Azzouz, Nicolas Gisch, Abhimanyu Amarnani
  Nature Reviews. Rheumatology. 2024-03-01

Journal Articles

• Review Targeting the Programmed Cell Death-1 Pathway in Rheumatoid Arthritis  
  Adam Mor, Greg J. Silverman, Sabina Sandigursky, ScienceDirect
• Rethinking the red wolf disease: Does Protein S suppress SLE clinical activity?  
  Silverman GJ, Arthritis Res Therapy, 1/1/2010
• Nucleic acid TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus  
  Kono DH, Haraldsson KM, Lawson BR, Pollard KM, Koh Y, Du X, Arnold CN, Baccala R, Silverman GJ, Beutler B, and Theofilopoulos AN, Proc Natl Acad Sci USA, 1/1/2009
• Pathogenic Natural Antibodies Recognizing Annexin IV Are Required to Develop Intestinal Ischemia-Reperfusion Injury  
  Kulik L, Fleming SD, Moratz C, Reuter JW, Novikov A, Chen K, Andrews KA, Markaryan A, Quigg RJ, Silverman GJ, Tsokos GC, Holers VM, J. Immunol., 1/1/2009
• IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells  
  Chen YF, Park YB, Patel E, Silverman GJ, J. Immunol., 1/1/2009
• Regulation of dendritic cells and macrophages by an anti-apoptotic-cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis  
  Chen Y, Khanna S, Goodyear CS, Park YB, Raz E, Thiel S, Grönwall C, Vas J, Boyle DL, Corr M, Kono DH, Silverman GJ, J. Immunol., 1/1/2009
• Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: The B-cell roadblock hypothesis  
  Silverman GJ, Boyle DL, Immunologic Reviews, 1/1/2008
• Therapeutic potential  
  Silverman, GJ, Linnick MD, Lupus, 1/1/2008
• Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and chemical oxidation  
  Catera R, Silverman GJ, Hatzi K, Seiler S, Didier S, Zhang L, Herve M, Meffre E, Oscier DG, Vlassara H, Scofield RH, Chen Y, Allen SL, Rai KR, Chu CC, Chiorazzi N, Molecular Medicine, 1/1/2008
• ituximab treatment of pulmonary arterial hypertension associated with systemic lupus erythematosus: A case report  
  Hennigan S, Channick RN, Silverman GJ, Lupus, 1/1/2008
• Genetic imprinting of autoantibody repertoires in SLE patients  
  Silverman GJ, Srikrishnan R. Germar K, Goodyear CS, Andrews KA, Ginzler EM, Tsao BP, Clin Exp Immunol, 1/1/2008
• Anti-CD20 Therapy and Autoimmune Disease  
  Silverman GJ, Frontiers in Biosciences, 1/1/2007
• B cell modulation in rheumatology  
  Silverman GJ Khanna S, Current Opinion in Pharmacology, 1/1/2007
• Cutting edge: Bim is required for superantigen mediated B-cell death  
  Goodyear CS, Corr M, Sugiyama F, Boyle D, Silverman GJ, Cutting edge: J Immunol, 1/1/2007
• Targeting of B cells in SLE: Rationale and Therapeutic Opportunities  
  Silverman GJ, NYU Bulletin, 1/1/2006
• Editorial: Therapeutic B-cell depletion and regeneration in rheumatoid arthritis: Emerging patterns and paradigms  
  Silverman GJ, Arthritis Rheum, 1/1/2006
• Confounding B-cell defenses: Lessons from a staphylococcal superantigen  
  Silverman GJ, Goodyear CS, Nature Reviews Immunology, 1/1/2006
• BAFF-Activated Classical and Alternative NF-B Pathways Mediate Retention of Autoreactive B-Cells in the Splenic Marginal Zone and Development of Lupus-like Autoimmune ...  
  Enzler T, Bonizzi G, Silverman GJ, Anzelon AN, Otero DC, Widhopf GF, Rickert RC, Karin M, Immunity, 1/1/2006
• Staphylococcus aureus Protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions  
  O'Seaghdha M, van Schooten CJ, Kerrigan SK, , Emsley J, Silverman GJ, Cox D, Lenting PJ, Foster TJ, FEBS Journal, 1/1/2006
• Blocking the a4 integrin-paxillin interaction selectively impairs lymphocyte recruitment to inflammatory sites  
  Chloe C F, Rose DM, Han J, Fox N, Silverman GJ, Kaushansky K, Ginsberg MH, J Clin Invest, 1/1/2006
• Temporal and Dose-dependent relationships between in vivo BCR-targeted proliferation and deletion induced by a microbial B-cell toxin  
  Goodyear CS, Sugiyama F, Silverman GJ, J Immunol, 1/1/2006
• B-cell Superantigens: A Microbe’s Answer to Innate-like B cells and Natural Antibodies  
  Goodyear, CS, Silverman GJ, Springer Semin Immunopathol, 1/1/2005
• Natural antibodies and innate-like B cells  
  Silverman GJ, Springer Semin Immunopathol, 1/1/2005
• Editorial: Anti-CD20 therapy in systemic lupus erythematosus: A step closer to the clinic  
  Silverman GJ, Arthritis Rheum, 1/1/2005
• Natural Antibodies and the Autoimmunity of Atherosclerosis  
  Binder, C.J., Silverman, G.J., Springer Seminars in Immunopathology, 1/1/2005
• Join now to see all